Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of FDG-PET Variability to Establish Biology-Guided Treatment Planning Feasibility for Stereotactic Body Radiation Therapy

NCT03493789 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03493789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03493789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of FDG-PET Variability to Establish Biology-Guided Treatment Planning Feasibility for Stereotactic Body Radiation Therapy
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
April 13, 2018
Completion date
March 19, 2019
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage i lung cancer, stage i non-small cell lung cancer ajcc v7, stage ia non-small cell lung carcinoma ajcc v7, stage ib non-small cell lung carcinoma ajcc v7, stage ii lung cancer, stage ii non-small cell lung cancer ajcc v7, stage iia non-small cell lung carcinoma ajcc v7, stage iib non-small cell lung carcinoma ajcc v7